I don't think its in a death spiral. But they do have to convince an investor or investors somehow that there is enough good evidence to justify further pursuing the investigation of the treatment. I suspect there is, but trials are expensive and take years, and there are no shortcuts. Someone has to ante up.
OSL Price at posting:
6.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)